Axon Closes a $1.15 Billion Zero-Coupon Convertible Deal
Axon raised $1.15 billion in convertible senior notes that pay no interest until 2031, paired them with capped calls to blunt dilution, and reworked its credit agreement.
Axon Enterprise (AXON) has closed a $1.15 billion offering of 0% convertible senior notes due 2031, using part of the proceeds to fund capped call transactions and amending its credit agreement to support future expansion.
Axon Enterprise (AXON) has completed a $1.15 billion sale of convertible senior notes that carry a 0% coupon and mature in 2031, a financing that hands the Taser and body-camera maker a large block of cash without an interest bill attached. Alongside the deal, the company funded capped call transactions designed to limit the share dilution the notes could eventually cause, and amended its existing credit agreement. The stated purpose of the raise is to support future expansion.
The terms, reported by GuruFocus, describe a structure that has become the default for high-multiple growth companies with strong equity stories: borrow long, pay nothing in cash, and let the conversion option do the work that a coupon would otherwise have to do.
What a 0% coupon actually buys
A convertible bond is a loan that the holder can swap for stock if the share price rises far enough. Investors accept a lower interest rate than they would demand on a straight bond because the embedded equity option has value. When the coupon is set at zero, as it is here, the bondholder is being paid entirely in optionality: no semi-annual interest, just the right to convert into Axon shares and the promise of principal back in 2031 if they do not.
For Axon, the arithmetic is straightforward. Over the life of the notes, the cash cost of servicing $1.15 billion of debt is nothing. That is a meaningful statement about how the market prices the company's equity volatility and growth trajectory — zero-coupon converts get done when investors believe the shares can travel a long way inside the term. It is also, in effect, a bet placed by Axon's finance team that issuing equity-linked paper today is cheaper than issuing equity outright or paying a cash coupon on senior debt.
The trade-off is that the obligation does not disappear. If the stock does not clear the conversion threshold, Axon owes the full $1.15 billion in 2031 and will have to refinance or repay it out of cash generation. Zero-coupon converts flatter near-term earnings and cash flow precisely because they defer the reckoning.
Why the capped call sits next to the notes
The capped call transactions are the part of the deal most retail holders skip over, and they are the reason the dilution headline is smaller than the raise size implies. A capped call is a derivative Axon buys from the banks involved in the offering. If the share price rises above the conversion price, the capped call pays Axon in shares or cash, offsetting some or all of the stock it would otherwise have to hand over to converting bondholders. The offset applies only up to a cap — beyond that level, dilution flows through.
In practical terms, the capped call raises the effective price at which existing shareholders begin to feel the deal. Axon pays for that protection out of the proceeds, so the net cash available for operations and expansion is less than $1.15 billion. The company has not disclosed, in the terms summarized here, the conversion price, the cap level or the cost of the hedge, so the precise dilution boundary cannot be calculated from what is public. Those figures will matter more to long-term holders than the headline size of the offering, and they are the numbers to look for in the accompanying filings.
One side effect worth understanding: banks that sell capped calls typically hedge by buying stock, which can support the shares around pricing, and they adjust those hedges as the price moves. That mechanical flow is separate from any view on the business.
The credit agreement amendment is the quieter signal
Amending the credit agreement at the same time as a large convertible issue usually means one of two things — loosening covenants so the new debt does not trip existing tests, or resizing and repricing a revolver to fit a bigger balance sheet. Either way, it points to a company deliberately building capacity rather than plugging a hole. Cash raised with no coupon and a 2031 maturity is optionality money: acquisitions, capacity, product build-out, or simply a buffer that lets management move without asking the market again.
For investors, the question is what the balance sheet is being positioned for. Axon has spent recent years widening from law-enforcement hardware into recurring software and cloud services, a mix shift that typically demands upfront investment before it shows up in margin. A five-year, interest-free $1.15 billion is well suited to exactly that kind of spending pattern.
Where the stock stood going in
Axon shares last traded at 447.76, down 1.27% on the session from a previous close of 453.50, with a day range of 446.37 to 458.00, as of the market close on Friday, 18 September 2026. The broad tape that day was mixed: the S&P 500 tracker (SPY) closed at $761.69, off 0.12%, the Dow 30 tracker (DIA) at $515.88, down 0.48%, while the Nasdaq 100 tracker (QQQ) finished at $721.45, up 0.63%.
Convertible issuance is often accompanied by short-term pressure on the underlying stock, because hedge funds buying the paper frequently short the equity to isolate the volatility component. That dynamic tends to fade once the deal is allocated and the notes begin trading.
What to watch from here
- The conversion price and cap level — these define exactly where dilution starts and where the hedge stops protecting shareholders.
- Net proceeds after the capped call — the usable cash figure, not the gross raise.
- The amended covenants — how much additional leverage the credit agreement now permits.
- Deployment — whether the money funds organic capacity or arrives in the form of an acquisition.
- Diluted share count — the line in future income statements where the notes will first become visible.
Zero-coupon paper is cheap money only if the growth thesis holds. Axon has bought itself five years to prove it.
Key facts
- Offering size: $1.15 billion of convertible senior notes
- Coupon and maturity: 0%, due 2031
- AXON last price: 447.76, -1.27%, as of 18 Sep 2026 20:00 GMT close
- Companion transactions: Capped call purchase and amended credit agreement
Frequently asked questions
What did Axon Enterprise actually issue?
Axon closed a $1.15 billion offering of convertible senior notes carrying a 0% coupon and maturing in 2031. Convertible notes are debt that holders can exchange for company stock if the share price rises above a set conversion level. Axon also funded capped call transactions and amended its existing credit agreement in connection with the deal.
Why would investors buy a bond that pays no interest?
Because they are paid in optionality rather than cash. The embedded right to convert into Axon shares carries value, and buyers are betting the stock will rise enough before 2031 to make conversion profitable. Many buyers are also hedge funds that trade the volatility component rather than holding for the equity upside alone.
What is a capped call and how does it help shareholders?
A capped call is a derivative the issuer buys from banks. If the share price rises above the conversion price, the capped call pays the company back in shares or cash, offsetting dilution that converting bondholders would otherwise cause. The protection applies only up to a cap; above that level, dilution reaches existing shareholders.
How much dilution will the notes cause?
That cannot be calculated from the disclosed terms. The conversion price, the cap level on the capped call and the cost of the hedge were not included in the summary of the transaction, and all three are needed to determine where dilution begins and how far the offset extends. Those details sit in the company's filings.
Why did Axon amend its credit agreement at the same time?
Issuers commonly amend credit agreements alongside large debt raises either to adjust covenants so the new borrowing does not breach existing limits, or to resize and reprice a revolving facility for a larger balance sheet. Either action expands financial flexibility, which fits the company's stated purpose of supporting future expansion.
Where was Axon stock trading around the deal?
Axon shares last traded at 447.76, a decline of 1.27% from the prior close of 453.50, with a session range of 446.37 to 458.00, as of the market close on 18 September 2026. Broad benchmarks were mixed that day, with the Nasdaq 100 tracker up 0.63% while the S&P 500 and Dow trackers slipped.
